JPMorgan Trust I has taken a significant step by filing a new prospectus for its U.S. Small Company Fund, aiming to provide investors with updated information on fees and expenses. This move is crucial as it reflects the company's ongoing commitment to transparency and investor awareness in a competitive market.
The updated prospectus outlines various classes of shares available, including Class R2, R3, R4, R5, and R6, along with their corresponding ticker symbols. The fund primarily targets investors looking for high total returns from a portfolio of small company stocks.
Background
Founded as JPMorgan Trust I, the company operates within the investment sector. It was previously known as JP Morgan Mutual Fund Series before its name change in 2003. The company is registered under the Central Index Key (CIK) 0001217286 and is incorporated in Delaware. It has recently filed multiple documents, including several 497K forms on October 27, 2026, highlighting its active engagement in regulatory compliance and investor communication.
What the Filing Says
The prospectus, effective as of November 1, 2026, provides a detailed breakdown of the fund's annual operating expenses. For instance, the management fees for all classes are listed at 0.60%, with additional distribution fees varying by class. The total annual fund operating expenses range from 0.72% to 1.48%, depending on the share class.
"Before you invest, you may want to review the Fund’s Prospectus, which contains more information about the Fund and its risks."
Impact
This update is likely to affect current and potential investors in the JPMorgan U.S. Small Company Fund. By providing a clearer understanding of the fees associated with the fund, investors can make more informed decisions regarding their investments. The filing also emphasizes the importance of transparency in the mutual fund industry, where competition is fierce.
What's Next
The filing does not say what happens next. However, investors are encouraged to review the updated prospectus and consider their investment strategies accordingly.
Read Next
Corgi ETF Trust I Sets New Effective Date for ETF Amendment
Nguyen Nam Tran increases stake in Generac Holdings Inc.
Basswood Financial Long Only Fund Amends SEC Filing on Dime
Andrade Robert Acquires Shares in Fennec Pharmaceuticals
Basswood Financial Long Only Fund sells shares of Dime Bancshares
Matthew Glickman increases stake in QuinStreet, Inc.









